PEPTRON
Peptron is a biotech company developing a wide range of peptide and small molecule based drugs to treat chronic and life-threatening disorders. Its initial focus is to provide long-term cure for neurodegenerative, cancer and endocrine related diseases. Peptron integrates the extensive experience of peptide research, drug development and expertise in drug delivery technologies for more than 15 years combined with a patients-focused approach driven by excellence.
PEPTRON
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
1997-11-21
Address:
Yusong, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.peptron.co.kr
Total Employee:
11+
Status:
Active
Contact:
042-360-8880
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag Mobile Non Scaleable Content US Privacy User Signal Mechanism PHP
Investors List
Agate Medical Investments
Agate Medical Investments investment in Venture Round - Peptron
Official Site Inspections
http://www.peptron.co.kr Semrush global rank: 6.85 M Semrush visits lastest month: 744
- Host name: 211.40.221.94
- IP address: 211.40.221.94
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Peptron"
Peptron - Crunchbase Company Profile & Funding
Peptron is a biotech company developing a wide range of peptide and small molecule based drugs to treat chronic and life-threatening disorders. Its initial focus is to provide long-term cure …See details»
Peptron
Organization 37-24, Yuseong-daero 1628 beon-gil, Yuseong-gu, Daejeon, 34054, Republic of Korea TEL +82-42-360-8880 / FAX +82-42-360-8888 / E-Mail : [email protected]See details»
Peptron Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Peptron Inc. of Daejeon, Daejeon. Get the latest business insights from Dun & Bradstreet. Peptron Inc. D&B …See details»
Peptron, Inc. (KOSDAQ: 087010) Company Profile & Overview
Oct 30, 2024 Peptron, Inc. engages in the development of peptide-based medicines. The company’s technologies include long acting; and SmartDepot, an ultrasonic spray drying …See details»
Peptron Inc. Company Profile - South Korea | Financials & Key
Jul 5, 2024 Full name: Peptron Inc. Profile Updated: July 05, 2024 Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a …See details»
Head Quarter - peptron.co.kr
Location: 37-24, Yuseong-daero 1628beon-gil, Yuseong-gu, Daejeon, 34054, Republic of Korea: Number: Tel 042-360-8880 / Fax 042-360-8888See details»
Company Peptron, Inc. - MarketScreener.com
Jun 30, 1999 Peptron, Inc. is a Korea-based company principally engaged in the development, manufacture and distribution of sustained-release medications. The Company mainly …See details»
Peptron, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Www.peptron.co.kr. Public Company | 1997 | Daejeon, South Korea | 50-100 | KRX: 087010 | www.peptron.co.kr. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Peptron
Organization; Corporate Governance; ... If you are interested in contacting Peptron regarding partnering opportunities, please email the Business Development Team at [email protected]. …See details»
Peptron Company Profile | Management and Employees List
Peptron Profile and History Since its foundation in 1997, Peptron Inc. has developed the fundamental technologies for creating sustained-release formulations to develop patient …See details»
087010.KR | Peptron Inc. Company Profile & Executives - WSJ
Company profile for Peptron Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed 087010.KR description & address.See details»
Peptron
Dr. Seung-Gu Chang has joined in Peptron for 20 years and served as various senior positions across a range of research and finance. In 2006, he was appointed Chief Financial Officer of …See details»
Peptron Inc. Company Profile | StatInvestor
Peptron, Inc. engages in the development of peptide-based medicines and novel drugs. Its products include medicines for prostate cancer, hyperpituitarism, diabetes, degenerative …See details»
Peptron - Products, Competitors, Financials, Employees, …
Peptron specializes in the development of sustained-release pharmaceuticals and peptide synthesis services within the biotechnology sector. The company offers custom peptide …See details»
Peptron - Company Profile - Tracxn
Nov 27, 2024 Peptron - Develop peptide-based medicines for cancer, diabetes & neurology disorders. Public Company. Raised funding from 10 investors. ... Website: peptron.co.kr; Email …See details»
Peptron
Since its foundation in 1997, Peptron Inc. has developed the platform technologies for peptide-based medicines. In line with proprietary technologies, we are developing sustained-release …See details»
Peptron - Overview, News & Similar companies | ZoomInfo.com
Who is Peptron. Since its foundation in 1997, Peptron Inc. has developed the fundamental technologies for creating sustained-release formulations to develop patien t-friendly, peptide …See details»
Parkinson’s Disease - peptron.co.kr
Organization; Corporate Governance; ... In 2014, Peptron licensed in the exclusive right of the National Institutes of Health(NIH) patent for the use of GLP-1 agonists for the treatment of …See details»
Partnering - Peptron
Organization; Corporate Governance; ... In Apr 2018, Peptron established own manufacturing facility in Osong, Korea, which can produce over 48,000 vials of SR-Exenatide per month. …See details»